SCHEMBL19007341

SCHEMBL19007341

Cc1cc(C)cc(-c2cccn2C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
CYP2A6 P11509 1/20 0.48
CYP2A13 Q16696 1/20 0.48
PCSK9 Q8NBP7 1/20 0.46
EPHX2 P34913 1/20 0.42
KDM4E B2RXH2 5/20 0.41
GAA P10253 2/20 0.41
BRD9 Q9H8M2 1/20 0.41
BRD7 Q9NPI1 1/20 0.41
MAPT P10636 3/20 0.37
ALOX12 P18054 2/20 0.37
ALOX15 P16050 1/20 0.37
NPC1 O15118 1/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ACHE P22303 1/20 0.35
TSHR P16473 2/20 0.34
APOBEC3A P31941 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
TRIM24 O15164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22607376 0.84 ALDH1A1 (0.40) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL17127671 0.84 ALDH1A1 (0.40) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL28310880 0.80 PCSK9 (0.52) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL6067863 0.77 ALDH1A1 (0.47) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL197196 0.75 PCSK9 (0.60) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL16435780 0.75 ALDH1A1 (0.42) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL6444709 0.75 PCSK9 (0.73) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL3188837 0.74 PCSK9 (0.50) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL18999650 0.74 PCSK9 (0.46) ALDH1A1CYP2A6CYP2A13PCSK9EPHX2
SCHEMBL20557374 0.74 ALDH1A1 (0.49) ALDH1A1CYP2A6CYP2A13PCSK9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174689-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174689-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL3 ALDH1A1 1900/4885CYP2A6 4451/4885CYP2A13 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.